Hutchinson S, et al. Rimegepant 75 mg demonstrates safety and tolerability similar to placebo: results from 3 phase 3 trials in adults with migraine. Abstract IHC-PO-133. IHC 2019 5-8 sept. Dublin, Ierland.
Epilepsie bij patiënten met primair CZS-lymfoom
okt 2024 | Epilepsie, Lymfoom